Immediate Impact

50 standout
Sub-graph 1 of 25

Citing Papers

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
1 intermediate paper

Works of Lynette J. Margesson being referenced

Hidradenitis Suppurativa
2010

Author Peers

Author Last Decade Papers Cites
Lynette J. Margesson 226 114 243 178 16 597
Stanley C. Marinoff 343 348 108 319 18 691
Catherine M. Leclair 93 137 49 239 33 584
Patty Greenberg 35 262 86 128 17 667
Ibrahim A. Abdel‐Hamid 103 41 38 355 37 695
Adrián Gaspar 175 359 83 131 16 543
Rong‐Hwang Fang 208 26 95 45 23 629
Marjan van den Berg 34 44 66 123 20 723
Uma Rajan 212 33 36 42 21 691
Stephen Foley 285 144 35 15 27 712
Bruce S. Kahn 111 324 25 65 20 657

All Works

Loading papers...

Rankless by CCL
2026